Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schütte

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Revue De Pneumologie Clinique|February 3, 2005
[Second-line chemotherapy in non-small-cell lung cancer]W Schütte
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1987
[Pathogenesis of hyperoxalurias and calcium oxalate calculi in intestinal diseases]G Müller, W Schütte, T Möller
Deutsche Medizinische Wochenschrift (1946)|December 6, 1996
[Tuberculosis of the middle ear: a rare extrapulmonary manifestation]W Schütte, A Berghaus, A Schütte
Pneumologie (Stuttgart, Germany)|February 23, 2005
[Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report]S Nagel, E Hobrack, P Jehle, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[A method for measuring oxalic acid absorption]G Müller, W Schütte, T Möller, et al.
Zeitschrift Fur Urologie Und Nephrologie|July 1, 1987
[Resorption of oxalic acid in calcium oxalate nephrolithiasis]G Müller, W Schütte, W Berg, et al.
Der Internist|April 20, 2002
[Dyspnea, eosinophilia and pulmonary infiltration in a 19-year-old drug dependent patient]S Opalka, K Lauerwald, C Schmidt, et al.
Pneumologie (Stuttgart, Germany)|July 11, 2009
[Treatment of respiratory papillomatosis--a case report on systemic treatment with bevacizumab]S Nagel, C Busch, T Blankenburg, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2013
[Implementation of the German guideline for the prevention, diagnosis, treatment and follow-up of non-small cell lung cancer at the Diakoniekrankenhaus Halle/Saale]M Witzmann, K-P Litwinenko, O Fischbeck, et al.
Acta Neurologica Scandinavica|January 30, 1999
Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter studyT Mayer, W Schütte, P Wolf, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Revue De Pneumologie Clinique|February 3, 2005
[Second-line chemotherapy in non-small-cell lung cancer]W Schütte
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1987
[Pathogenesis of hyperoxalurias and calcium oxalate calculi in intestinal diseases]G Müller, W Schütte, T Möller
Deutsche Medizinische Wochenschrift (1946)|December 6, 1996
[Tuberculosis of the middle ear: a rare extrapulmonary manifestation]W Schütte, A Berghaus, A Schütte
Pneumologie (Stuttgart, Germany)|February 23, 2005
[Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report]S Nagel, E Hobrack, P Jehle, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[A method for measuring oxalic acid absorption]G Müller, W Schütte, T Möller, et al.
Zeitschrift Fur Urologie Und Nephrologie|July 1, 1987
[Resorption of oxalic acid in calcium oxalate nephrolithiasis]G Müller, W Schütte, W Berg, et al.
Der Internist|April 20, 2002
[Dyspnea, eosinophilia and pulmonary infiltration in a 19-year-old drug dependent patient]S Opalka, K Lauerwald, C Schmidt, et al.
Pneumologie (Stuttgart, Germany)|July 11, 2009
[Treatment of respiratory papillomatosis--a case report on systemic treatment with bevacizumab]S Nagel, C Busch, T Blankenburg, et al.
Pneumologie (Stuttgart, Germany)|November 14, 2013
[Implementation of the German guideline for the prevention, diagnosis, treatment and follow-up of non-small cell lung cancer at the Diakoniekrankenhaus Halle/Saale]M Witzmann, K-P Litwinenko, O Fischbeck, et al.
Acta Neurologica Scandinavica|January 30, 1999
Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter studyT Mayer, W Schütte, P Wolf, et al.
Pageof 4